查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1883833

全球数位PCR市场

Digital PCRs
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到2030年，全球数位PCR市场规模将达到3.719亿美元。

据估计，2024年全球数位PCR市场规模为2.345亿美元，预计到2030年将达到3.719亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为8.0%。本报告分析的基础研究应用领域预计复合年增长率为8.0%，到分析期末将达到1.507亿美元。临床诊断应用领域预计在分析期间内复合年增长率为8.5%。

美国市场规模估计为6,550万美元，而中国市场预计将以7.5%的复合年增长率成长。

预计到2024年，美国数位PCR市场规模将达6,550万美元。作为世界第二大经济体，中国预计到2030年市场规模将达到5,710万美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）为7.5%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为7.5%和6.5%。在欧洲，德国预计将以约6.4%的复合年增长率成长。

全球数位PCR市场—主要市场趋势与驱动因素概述

什么是数位PCR？为什么说它是分子生物学领域的革命性技术？

数位PCR (dPCR) 是一种高精度、高灵敏度的分子技术，用于定量和扩增DNA或RNA。此技术将样本分成多个独立的反应体系。 PCR扩增后，分析每个反应体系，以确定目标序列的存在与否，从而提供比传统PCR更精确的定量结果。数位PCR无需参考标准品或内参即可达到绝对定量。这显着提高了检测低表达标靶、评估基因表现量和分析遗传变异的可靠性。该技术在临床诊断、个人化医疗和环境生物学等领域尤其重要，因为在这些领域，精确测量至关重要。

科技进步如何提升数位PCR的性能？

近年来，数位PCR技术的进步体现在流体动态、微流体和软体分析等方面，显着提升了系统的精确度、易用性和通量。液滴数位PCR (ddPCR) 和晶片数位PCR (dPCR) 等创新技术透过增加分析区域的数量，提高了灵敏度和精确度，从而彻底革新了该领域。这些进步使得研究人员能够以前所未有的精度检测血液样本中低浓度的肿瘤DNA等稀有DNA标靶。此外，自动化和即时数据分析软体的整合降低了人为误差的可能性，并简化了工作流程。这些优势使得数位PCR成为适用于高通量环境下常规应用的强大工具。

数位PCR技术将推动哪些应用？

除了基础研究之外，数位PCR在许多应用领域的重要性日益凸显。在临床诊断中，它被用于早期检测癌症突变和感染疾病、监测微量残存疾病以及追踪治疗效果，从而直接影响患者的治疗方案和预后。在环境监测中，数位PCR能够检测土壤和水样本中低浓度的病原体和基因改造生物（GMO）。此外，在快速发展的液态生物检体领域，它透过检测和定量循环肿瘤DNA（ctDNA）来支持非侵入性癌症诊断，为早期诊断、预后评估和疾病监测提供了强有力的工具。数位PCR的高灵敏度和高准确性使其在各个应用领域中得到应用，并推动其融入这些重要的研究和应用领域。

哪些因素正在推动数位PCR市场的成长？

数位PCR市场的成长受多种因素驱动，包括对精准分子诊断和个人化医疗日益增长的需求，而这些需求需要强大的定量技术。遗传疾病和癌症的日益普遍，以及人们对液态生物检体的认识不断提高和临床应用日益广泛，进一步推动了对数位PCR技术的需求。提高数位PCR系统效率和降低成本的技术创新也促进了市场扩张。此外，数位PCR在食品安全、环境监测和农业生物学等领域的应用范围不断扩大，凸显了其多功能性和有效性，吸引了来自各个领域的投资。这些因素，加上数位PCR系统的持续改善和对精准诊断日益增长的关注，有望推动数位PCR市场持续成长，体现其在分子生物学和临床诊断未来发展中的重要作用。

部分：

产品（仪器、耗材、服务）、应用（基础研究、临床诊断、其他应用）、最终用途（研究机构、製药公司、其他最终用途）

受访公司范例

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来变革市场和竞争情报。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP11555

Global Digital PCRs Market to Reach US$371.9 Million by 2030

The global market for Digital PCRs estimated at US$234.5 Million in the year 2024, is expected to reach US$371.9 Million by 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Basic Research Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$150.7 Million by the end of the analysis period. Growth in the Clinical Diagnostics Application segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.5 Million While China is Forecast to Grow at 7.5% CAGR

The Digital PCRs market in the U.S. is estimated at US$65.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$57.1 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.5% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Digital PCRs Market - Key Trends and Drivers Summarized

What Is Digital PCR and Why Is It a Game-Changer in Molecular Biology?

Digital PCR (dPCR) is a highly precise and sensitive molecular technique used to quantify and amplify DNA or RNA. This method partitions a sample into many individual reactions. After PCR amplification, each partition is analyzed to determine the presence or absence of the target sequence, allowing for more accurate quantification than traditional PCR methods. Digital PCR provides absolute quantification without the need for reference standards or internal controls, which significantly enhances its reliability for detecting low-abundance targets, assessing gene expression levels, and analyzing genetic variations. This technology is particularly valuable in clinical diagnostics, personalized medicine, and environmental biology, where precise measurements are crucial.

How Are Technological Advancements Refining Digital PCR Capabilities?

Recent technological advancements in digital PCR include improvements in fluid dynamics, microfluidics, and software analytics, which enhance the accuracy, usability, and throughput of these systems. Innovations such as droplet digital PCR (ddPCR) and chip-based dPCR have revolutionized the field by increasing the number of partitions analyzed, thereby providing greater sensitivity and precision. These advancements allow researchers to detect rare DNA targets, such as low-abundance tumor DNA in blood samples, with unprecedented accuracy. Furthermore, the integration of automation and real-time data analysis software reduces the potential for human error and streamlines the workflow, making digital PCR a robust tool for routine use in high-throughput settings.

What Applications Are Driven by Digital PCR Technology?

Digital PCR is becoming increasingly crucial across various applications beyond basic research. In clinical diagnostics, it is used for early detection of cancer mutations and infectious diseases, monitoring minimal residual disease, and tracking treatment efficacy, which can directly influence patient treatment plans and outcomes. In the field of environmental monitoring, dPCR enables the detection of low-levels of pathogens or GMOs in soil and water samples. Additionally, in the burgeoning field of liquid biopsy, dPCR helps in non-invasive cancer diagnostics by detecting and quantifying circulating tumor DNA, offering a powerful tool for early diagnosis, prognosis, and disease monitoring. Each application benefits from dPCR’s high sensitivity and precision, driving its integration into these critical areas of study and application.

What Drives the Growth in the Digital PCR Market?

The growth in the digital PCR market is driven by several factors, including the increasing demand for precise molecular diagnostics and personalized medicine, which require robust quantitative techniques. The rising prevalence of genetic disorders and cancer, coupled with growing awareness and clinical adoption of liquid biopsies, further fuels the demand for digital PCR technology. Technological innovations that enhance the efficiency and reduce the cost of dPCR setups also contribute to market expansion. Additionally, the broadening applications of dPCR in food safety, environmental monitoring, and agricultural biology emphasize its versatility and effectiveness, attracting investment from various sectors. These factors, combined with the ongoing improvements in digital PCR systems and a growing emphasis on precision diagnostics, ensure that the market for dPCR will continue to expand, reflecting its critical importance in the future of molecular biology and clinical diagnostics.

SCOPE OF STUDY:

The report analyzes the Digital PCRs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Instruments, Consumables, Services); Application (Basic Research, Clinical Diagnostics, Other Applications); End-Use (Research Institutes, Pharmaceutical Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Digital PCRs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine Propels Adoption of Digital PCRs
    • Increasing Use of Digital PCR in Cancer Diagnostics Expands Market Opportunities
    • Expanding Applications of Digital PCR in Infectious Disease Testing Sets the Stage for Market Growth
    • Rising Adoption of Digital PCRs in Liquid Biopsy Technologies Drives Market Expansion
    • Increasing Use of Digital PCRs in Agricultural Biotechnology Bodes Well for Market Growth
    • Growing Focus on Non-Invasive Prenatal Testing (NIPT) Spurs Adoption of Digital PCRs
    • Growing Use of Digital PCR in Environmental Testing Expands Addressable Market
    • Expansion of Digital PCR in Food Safety Testing Generates Market Opportunities
    • Rising Prevalence of Genetic Disorders Sets the Stage for Growth in Digital PCR Market
    • Development of Portable Digital PCR Devices Bodes Well for Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Basic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Digital PCRs Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION